About Vericel corporation
Vericel Corporation: Revolutionizing Sports Medicine and Severe Burn Care with Advanced Cell Therapies
Vericel Corporation is a leading biopharmaceutical company that specializes in the development and commercialization of advanced cell therapies for the sports medicine and severe burn care markets. The company's innovative products are designed to help patients recover from injuries faster, reduce pain, and improve their quality of life.
Founded in 1989 as Aastrom Biosciences, Vericel has been at the forefront of regenerative medicine for over three decades. The company's mission is to provide patients with safe, effective, and affordable treatments that harness the power of their own cells to promote healing.
Vericel's flagship product is MACI (autologous cultured chondrocytes on porcine collagen membrane), an advanced cell therapy that is used to treat cartilage defects in the knee. MACI has been approved by regulatory agencies in Europe, Canada, Australia, New Zealand, and other countries around the world. In addition to MACI, Vericel also offers Epicel (cultured epidermal autografts), a cell-based therapy for severe burns.
Sports Medicine: How Vericel Is Changing The Game
Sports injuries can be devastating for athletes at any level. Whether it's a torn ACL or a damaged meniscus, these injuries can sideline players for months or even years. Traditional treatments such as physical therapy or surgery may not always be effective in restoring full function to injured joints.
This is where Vericel comes in with its revolutionary approach to sports medicine. By using a patient's own cells to repair damaged tissue instead of relying on synthetic materials or donor tissues that may not integrate well into the body - Vericel offers an alternative treatment option that can help athletes get back on their feet faster than ever before.
MACI works by taking healthy cartilage cells from an uninjured part of the patient's knee joint and growing them outside the body under controlled conditions. These cells are then implanted onto a collagen membrane which acts as a scaffold for new tissue growth when placed into the injured area during surgery.
The result? A new layer of healthy cartilage grows over time which helps restore normal joint function while reducing pain levels significantly compared with traditional treatments like physical therapy alone or surgical intervention without cell-based therapies like MACI.
Severe Burn Care: How Epicel Is Helping Patients Heal Faster
Severe burns are among some of the most painful injuries anyone can experience - both physically and emotionally. They often require extensive medical treatment including skin grafts which can take weeks if not months before they fully heal leaving scars behind long after recovery has taken place.
Epicel changes all this by providing patients with an alternative treatment option that uses their own skin cells instead of donor tissues which may not integrate well into their bodies leading potentially dangerous complications down-the-line such as rejection reactions etcetera...
Epicels' process involves taking small samples from undamaged areas on your body called "donor sites" where there isn't any burn damage yet available; these samples are then grown outside your body under controlled conditions until they form sheets large enough cover burned areas completely without leaving any gaps between them so new skin growth occurs quickly without scarring issues arising later down-the-line due mismatched donor tissues being used instead!
The Future Of Regenerative Medicine With Vericell
As we move forward into an era where regenerative medicine becomes more prevalent than ever before - companies like Vericell will continue playing vital roles developing innovative solutions addressing unmet medical needs across various therapeutic areas including orthopedics/severe burns care etcetera...
With its cutting-edge technology platforms combined expertise within fields ranging from stem-cell biology through clinical development phases up-to commercialization stages; there’s no doubt whatsoever about how much potential lies ahead waiting be unlocked through continued research efforts aimed towards advancing regenerative medicines further still!
vcel.com